Cases & Deals

Nanobiotix completes €27.2 million placement of new shares

Clients Nanobiotix

Jones Day advised Nanobiotix, an oncology focused nanomedicine company listed on the regulated market of Euronext in Paris, in connection with its €27.2 million (US$31.6 million) placement of new shares to U.S. and European investors.